Navigation Links
ViewRay to Showcase its MRIdian System in Booth 639 at 2014 Medical Physics Meeting
Date:7/18/2014

CLEVELAND, July 18, 2014 /PRNewswire/ -- ViewRay™ Incorporated, a privately held medical device company, will be featuring its MRIdian™ (me-rid-i-an) system in booth 639 at the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM), which will be held July 20-24 in Austin, TX.

The MRIdian system – the world's first and only MRI-guided radiation therapy system – is designed to improve the accuracy of cancer treatments through a patented combination of simultaneous Magnetic Resonance Imaging (MRI) and radiation therapy delivery. With continuous soft-tissue imaging, clinicians can clearly see the cancer target, monitor where the actual radiation dose is being delivered, and adapt to changes in the patient's anatomy – all in real time, providing a more precise and personalized cancer treatment option.

AAPM, the largest association of medical physicists in the world, has selected six "hot topics" for its 2014 annual meeting, including MRI-guided radiation therapy. The topic will be highlighted in several tracks during the conference including a session titled MRI in the Treatment Room, featuring early adopters of the MRIdian system from Siteman Cancer Center and Washington University School of Medicine, which will be held on Wednesday, July 23, at 4:30 p.m. in Room 17A.  Ten abstracts from Siteman focused on research with the MRIdian system have been selected for oral and poster presentations at this year's meeting. For a comprehensive look at AAPM 2014 sessions, download the meeting program here.

First patient treatments on the MRIdian system began in January of 2014 at the Siteman Cancer Center in St. Louis, Mo. Since the launch of its MRI-guided RT program, the center has treated a wide array of disease sites including breast, bladder, lung, pancreas and stomach. Clinical applications experts from ViewRay will be available in booth 639 at AAPM to demonstrate treatment planning and delivery functionality of the system.

About ViewRay
ViewRay Incorporated of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. The MRIdian (me-rid-i-an) system provides continuous soft-tissue imaging during treatment, using MRI-guided radiotherapy, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. For more information, visit http://www.viewray.com.

ViewRay and MRIdian are trademarks of ViewRay Incorporated.

ViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.


'/>"/>
SOURCE ViewRay
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
2. Siteman Cancer Center at Barnes-Jewish and Washington University Begins Imaging with First ViewRay System
3. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
4. CIVCO to Showcase Protura and Varian Interface at AAPM 2014
5. Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco
6. NW Bio To Present At Biotech Showcase 2014
7. Soligenix to Present at the 2014 Biotech Showcase in San Francisco
8. G1 Therapeutics to Present at Biotech Showcase 2014
9. Salutron, Inc. Showcases Benefits of Heart Rate Measurement in Activity Monitoring at ShowStoppers and CES 2014
10. Aethlon Medical to Present at Biotech Showcase Investor Conference
11. BioLineRx to Present at Biotech Showcase Conference in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... Leading Economies with Fastest Real GDP Annual Percentage Change, 2015  ... 7.3, , Source: IMF and TechSci Research   ... Brazil , Russia , India , ... the fastest GDP growth during the first decade of the 21 st ... Brazil and Russia , along with policy ...
(Date:5/2/2016)...  While nearly three-quarters of Americans (71%) are aware ... health, only about half report taking any steps to ... a new survey announced today by Hologic (Nasdaq: ... Osteoporosis Month, Hologic is raising awareness of this major ... Americans. Osteoporosis is a disease that causes ...
(Date:5/2/2016)... May 2, 2016 The ... USD 11.1 billion by 2024, according to a ... Major drivers of the sonography market include expanding ... government recommendations for periodic ultrasound screenings of the ... http://photos.prnewswire.com/prnh/20150105/723757 ) High Intensity ...
Breaking Medicine Technology:
(Date:5/2/2016)... CHICAGO (PRWEB) , ... May 02, 2016 , ... ... comprehensive treatment for eating, mood and anxiety disorders, has rebranded its eating disorder program ... a new residential eating disorder treatment facility on May 16. , To celebrate, ...
(Date:5/2/2016)... ... May 02, 2016 , ... The National Resident Matching Program® ... Match® (“the Match”), the system through which U.S. and international medical school students ... positions were placed in the 2016 Match, and 29,572 were filled when the ...
(Date:5/2/2016)... ... May 02, 2016 , ... East Los Angeles dentist , ... can visit Dr. Assili to receive any dental extraction treatment for $40 off the ... June 30, 2016. With the lower price, patients can more easily afford extractions to ...
(Date:5/2/2016)... Vegas, NV (PRWEB) , ... May 02, 2016 ... ... Specialty Pharmacy Times, has announced a new Specialty Pharmacy Patient Satisfaction Award that ... determined based on the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... prescription medications, including anxiolytics, painkillers, antidepressants and cholesterol-lowering drugs, may cause cognitive ... Detox Center —a leading Florida-based drug treatment facility—advises patients to research the ...
Breaking Medicine News(10 mins):